Business
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy.
About this update from Glucose Health, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy\r\n \r\n \r\n\r\n\r\nGlucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy\r\n\r\n\r\n\r\n\r\n\r\nBENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members of the Board of Directors holding preferred shares elected to convert their shares, along with all other preferred shareholders, at a shareholder-friendly 85% premium to the market price. Glucose Health, Inc. Board Member, Chris Jemapete stated: “Some of the preferred series carried dividends with quarterly cash payments to shareholders. In one of our first actions as new Board members, we concluded that cash on hand should be prioritized to finance the future growth of the Company and its national soluble fiber nutrition brands, rather than paying dividends to shareholders, ourselves included.” Mr. Jemapete further noted: “By converting the preferred shares into common stock, we were able to eliminate a major liability on the Company’s balance sheet and streamline the cap table into a now straightforward structure for financing our planned strategic growth initiatives.” Glucose Health, Inc. Board Member, Ned Burke added: “We intend to focus our efforts on three main areas: financing growth, increasing the number of distribution channels, and reaching profitability. It is the Board’s clear intention to build a company with strong corporate governance and a complete business structure.” Mr. Burke further noted: “From 2019 to 2022, Glucose Health, Inc.’s revenues rapidly increased from $291,213 to $1,072,655 – a Compound Annual Growth Rate of 38.54%. The Company achieved this impressive growth with Amazon being its most important distribution channel. Today, in 2026, having achieved national in-store placement of GlucoDown at the nation’s two largest and most respected pharmacy chains, CVS and Walgreens, and with the successful launch of our new fiber supplement brand Fi...